Purchase Order N0025919P0443
Award Date 9/27/19
Potential Completion Date 9/30/24
Potential Value $66K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price purchase order awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, to Cerus Corporation, a biomedical company specializing in blood safety technologies and pathogen reduction systems. The $82,389 contract is for the supply of INTERCEPT Illuminator 60 Hz systems and associated maintenance services. The illuminators are essential components of Cerus Corporation's proprietary INTERCEPT Blood System,...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price purchase order to Cerus Corporation, a biomedical products manufacturer, for the procurement of 2 INTERCEPT ILLUMINATOR 60HZ - INT100-60 units. The $110,000.00 contract has a completion date of September 8, 2017. Cerus Corporation has received over 20 prime federal contracts from agencies such as the Defense Health Agency, Department of Defense, and Department of Veterans Affairs to provide goods and services...
- The Defense Health Agency awarded a Firm Fixed Price, $186,048.00 purchase order contract to Cerus Corporation, a biomedical products manufacturer, for the drop shipment of medical supplies. The contract is sole source and not set aside. The supplies include the INTERCEPT Blood System technology, which uses riboflavin and UV light to inactivate pathogens in blood platelets and plasma. Cerus has received over 20 federal contract awards since 2002 from agencies such as the Department of Defense,...
- This firm fixed price purchase order was awarded by the Defense Health Agency to Cerus Corporation for annual preventative maintenance of Intercept Illuminators located at Portsmouth, Virginia. Valued at $66,388, the contract includes a base year and four option years of maintenance and support for illuminators used to treat blood products. The sole source justification indicates the equipment requires specialized maintenance that can only be performed by the original equipment manufacturer....
- This is a $133,640.00 firm fixed price purchase order awarded by the Defense Health Agency to Cerus Corporation, a small business manufacturer of biomedical products. The contract is for the provision of illuminator equipment and related maintenance services, with a completion date of October 24, 2019. Cerus has received over 20 previous federal contracts from agencies including the Department of Defense, Department of Veterans Affairs, and Department of Health and Human Services to provide...
- The Defense Health Agency (DOD) awarded a $367,504.80 firm fixed price purchase order to Cerus Corporation to provide INTERCEPT Platelet Processing and Service Maintenance for the Walter Reed National Military Center in Bethesda, Maryland from January 13, 2022 through January 31, 2027. Cerus Corporation will supply its INTERCEPT Blood System for platelets, which utilizes ultraviolet light and riboflavin to inactivate pathogens in platelet components during the collection and storage process,...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The $138,800 firm-fixed-price contract is for the supply of INTERCEPT Illuminator 60 Hz equipment and INTERCEPT Platelet Processing Sets with Dual Storage, as well as related services, to support the agency's blood product safety requirements. Cerus Corporation's proprietary INTERCEPT Blood System uses...
- The Defense Health Agency awarded a firm fixed-price purchase order to Cerus Corporation for $367.1K on October 1, 2025, with an ultimate completion date of September 30, 2030. The contract covers Cerus Intercept Platelet Processing Sets, specialized medical equipment used in blood pathogen reduction treatment. Cerus Corporation, a biomedical products manufacturer headquartered in Concord, California, specializes in blood safety technologies and the proprietary INTERCEPT Blood System, which uses...
- The Defense Health Agency has awarded Cerus Corporation, a for-profit manufacturer of biomedical products, a $87,166.08 firm fixed price purchase order contract to provide the INTERCEPT Blood System for Platelets. This pathogen reduction technology uses riboflavin and UV light to inactivate viruses, bacteria, protozoa, and contaminating white blood cells in platelet components. The contract, which does not have a set-aside designation, will run through June 18, 2024. Cerus has received over 20...
- The Defense Health Agency awarded a $104,256 firm fixed-price purchase order to Cerus Corporation on September 30, 2019, for INTERCEPT Platelet Small Volume Sets, with performance through September 3, 2024. The contract was awarded without a set-aside designation to Cerus Corporation, a Concord, California-based biomedical products manufacturer specializing in blood safety technologies. Cerus's INTERCEPT Blood System uses riboflavin and ultraviolet light technology to inactivate pathogens in...